SlideShare una empresa de Scribd logo
1 de 8
Material Safety Data Sheet 
Version 1.1 
Revision Date: 06/05/2014 
Print Date: 08/06/2014 
1. PRODUCT AND COMPANY IDENTIFICATION 
Product name: COSMESOME TM- Res (NE) 
Product Number: COS-1009 
Brand: COSMESOME TM 
Company Address: ENCAPSULA NANOSCIENCES LLC 
6 CADILLAC DRIVE SUITE 245 
BRENTWOOD, TN, 37027 
Technical Phone: 615-884-4442 
Fax: 615-250-8747 
Emergency Phone: 615-438-8553 
CHEMTREC: 1-800-424-9300 
2. COMPOSITION/INFORMATION ON INGREDIENTS 
Ingredient Name CAS# Percent 
WATER 7732-18-5 >90 
GLYCERIN 56-81-5 
1, 3 Butanediol 107-88-0 <5 
3,5,4-TRIHYHROXY-TRANS-STILBENE 501-36-0 
L-α-PHOSPHATIDYLCHOLINE, hydrogenated 97281-48-6 <5 
3. HAZARDS IDENTIFCATION 
OSHA 
No known OSHA hazards 
TARGET ORGANS 
Skin, Respiratory, Eyes 
WHMIS HAZARD CLASS 
D1B toxic materials 
D2B toxic materials 
HMIS RATING 
HEALTH HAZARDS: 1 
FLAMMABILITY: 1 
CHRONIC HEALTH HAZARDS: * 
PHYSICAL HAZARDS: 0
Material Safety Data Sheet 
Version 1.1 
Revision Date: 06/05/2014 
Print Date: 08/06/2014 
NFPA RATING 
HEALTH HAZARD: 2 
FLAMMABILTY: 1 
REACTIVITY: 0 
POTENTIAL HEALTH EFFECTS 
Inhalation May be harmful if inhaled. 
Skin May be harmful if absorbed through skin 
Eyes May cause eye irritation. 
Ingestion May be harmful if swallowed. 
Chronic No existing conditions have been investigated 
4. FIRST AID MEASURES 
ORAL EXPOSURE 
Do not induce vomiting. Never give anything by mouth to an unconscious person. Rinse mouth with 
water. Consult a physician 
INHALATION EXPOSURE 
If inhaled, remove to fresh air. If not breathing give artificial respiration. If breathing is difficult, give 
oxygen. Do not use mouth to mouth resuscitation. Consult a physician. 
DERMAL EXPOSURE 
In case of contact, immediately wash skin with soap and copious amounts of water. Cover skin with 
an emollient. Contact a physician. 
EYE EXPOSURE 
In case of contact, check or remove any contact lenses; immediately flush eyes with copious amounts 
of water for at least 15 minutes. Contact a physician. 
5. FIRE FIGHTING MEASURES 
FLAMMABILITY 
Not available 
EXTINGUISHING MEDIA 
It is suitable to use water spray, alcohol -resistant foam, dry chemical or carbon dioxide.
Material Safety Data Sheet 
Version 1.1 
Revision Date: 06/05/2014 
Print Date: 08/06/2014 
SPECIAL PROCTECTIVE EQUIPMENT FOR FIRE-FIGHTERS 
Wear self-contained breathing apparatus and protective clothing to prevent contact with skin and 
eyes. Included a positive pressure NIOSH approved self-contained breathing apparatus. 
HAZARDOUS COMBUSTION PRODUCTS 
Carbon oxides 
SPECIAL REMARKS 
Not available 
ACCIDENTAL RELEASE MEASURES 
METHODS FOR CLEANING UP 
Soak up inert absorbent material and dispose of as waste. Keep in suitable container for disposal. 
Use appropriate tools to put this spilled solid in a convenient waste disposable container and finish 
cleaning by spreading water on the contaminated surface and dispose of according to local and 
region authority requirements. Allow to evacuate through the sanitary system 
ENVIRONMENTAL PRECAUTIONS 
Do not let product enter drains. If safe to do so prevent further leakages or spills. 
PERSONAL PRECAUTIONS 
Use personal protective equipment. Avoid breathing in vapors, mist or gas. Ensure adequate 
ventilation. Prepare evacuation sites. 
6. HANDLING AND STORAGE 
HANDLING 
User Exposure: Do not breathe vapor, dust, fume, gas, mist and spray. Avoid prolonged or repeated 
exposure. Do not get in eyes, on skin, on clothing. Wash hands thoroughly after handling. 
STORAGE 
Suitable: Keep tightly container closed. Store in temperature between approximately 2-8 o C. Do not 
freeze keep in refrigerator. Product is sensitive to moisture and light. Keep product and empty 
container away from heat and sources ignition. 
7. EXPOSURE CONTROLS/ PERSONAL PROTECTION 
ENGINEERING CONTROLS 
Safety shower and eye bath. Mechanical exhaust required.
Material Safety Data Sheet 
Version 1.1 
Revision Date: 06/05/2014 
Print Date: 08/06/2014 
PERSONAL PROTECTIVE EQUIPMENT 
Respiratory: Use respirators and components tested and approved under appropriate government 
standards such as NIOSH (US) in accord with 29 CFR 1910.134 or EN 149, use either an atmosphere 
supply respirator or air purifying respirator. Also follow face protection regulations in 29 CFR 
1910.133 or European standard EN 166. Also use a full -face respirator with multi -purpose 
combination (US) or type ABEK (EN 14387) respirator cartridges as a back up to engineering 
controls. If the respirator is the sole means of protection, use a full -face supplied airs respirator. 
Use respirators and components tested and approved under appropriate government standers 
such as NIOSH (US) or CEN (EU). 
Hand: Compatible chemical -resistant gloves. 
Eye: Chemical safety goggles. Safety glasses with side-shields conforming to EN 166 use equipment 
for eye protection listed and approved under appropriated government standards such as NIOSH 
(US) or EN166 (EU) 
Skin and Body: Wear a complete suit protecting against chemicals. 
GENERAL HYGIENE MEASURES 
Wash hands thoroughly after handling. Wash contaminated clothing before reuse. Prepare all 
materials under the fume hood and avoid generating aerosols. 
8. PHYSICAL AND CHEMICAL PROPERTIES 
Appearance 
white, viscous liquid 
Safety data 
N/A 
Melting point 
N/A 
Boiling point 
N/A 
Flash point 
N/A 
Ignition Temperature 
N/A 
Lower explosion limit 
N/A 
Upper Explosion limit 
N/A 
Water Solubility 
N/A
Material Safety Data Sheet 
Version 1.1 
Revision Date: 06/05/2014 
Print Date: 08/06/2014 
Density 
N/A 
9. STABILITY AND REACITIVITY 
STORAGE STABILITY 
Store under recommended conditions. 
MATERIALS TO AVIOD 
Strong oxidizing agents, strong acids 
HAZARDOUS DECOMPOSITION PRODUCTS 
N/A 
CONDITIONS TO AVOID 
Light and exposure to moisture. Strong bases and Strong oxidizing agents. 
10. TOXICOLOGICAL INFORMATION 
CARCINOGENICITY 
This product contains a component that has been reported to be carcinogenic based on its IARC, OHSA, ACGIH, 
NTP, or EPA classification. 
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as 
probable, possible or confirmed human carcinogen by the IARC. 
OHSA: No component of this product present at levels greater than or equal to 0.1% is identified as 
probable, possible or confirmed human carcinogen by the OHSA. 
ACGIH: No component of this product present at levels greater than or equal to 0.1% is identified as 
probable, possible or confirmed human carcinogen by the ACGIH. 
EPA: No component of this product present at levels greater than or equal to 0.1% is identified as 
probable, possible or confirmed human carcinogen by the EPA. 
CHRONIC. 
Only select Regeristory or Toxic of Chemical Substances (RTECS) data as presented here. See 
actual entery RTECS for complete information. Product is harmful by ingestion. 
Repeated contact may cause allergic reactions in very susceptible persons. 
ACUTE TOXICITY 
1,3-Butanediol : Oral LD50- mouse rat-698 mg/kg 
Symptoms: Sense organs and special senses (eye-lacrimation; muscle weakness; diarrhea) 
Dermal LD50- rabbit >20,000 mg/kg 
Glycerin: Oral LD50- mouse rat-698 mg/kg
Material Safety Data Sheet 
Version 1.1 
Revision Date: 06/05/2014 
Print Date: 08/06/2014 
Symptoms: Sense organs and special senses (eye-lacrimation; muscle weakness; diarrhea) 
Dermal LD50- rabbit >20,000 mg/kg 
ADDITIONAL INFORMATION 
Prolonged or repeated exposure may result in Nausea, Headache, or Vomiting 
Kidney- irregularities-based on Human evidence 
ROUTE OF EXPOSURE 
Skin Contact: May cause skin irritation. May produce an allergic reaction. 
Skin Absorption: May be harmful if absorbed through the skin 
Eye Contact: May Cause eye irritation and risk serious damage 
Inhalation: Materials may be irritating to mucous membranes and upper respiratory tract. 
Ingestion: May be harmful if swallowed. Ingestion may cause gastrointestinal irritation, 
nausea, vomiting and diarrhea. 
SIGNS AND SYMPTOMS OF EXPOSURE 
Symptoms have not be thoroughly investigated 
11. ECOLOGICAL INFORMATION 
Elimination information (persistence and degradability) 
N/A 
Ecotoxicity effects 
N/A 
Further information on ecology 
N/A 
12. DISPOSAL CONSIDERATIONS 
PRODUCT 
Observe all federal, state, and local environment regulations. Contact a licensed professional waste 
disposal service to remove this material . 
CONTAMINATED PACKAGING 
Observe all federal, state, and local environment regulations. 
13. TRANSPROT INFORMATION 
DOT (US) 
Not dangerous goods
Material Safety Data Sheet 
Version 1.1 
Revision Date: 06/05/2014 
Print Date: 08/06/2014 
IMDG 
Not dangerous goods 
IATA 
Not dangerous goods 
15. REGULATORY INFORMATION 
OSHA HAZARDS 
OSHA: Hazardous by definition of Hazard Communication Standard (29 SFR 1910.1200). EINECS: 
this product is on the European Inventory of Existing Commercial Chemical Substances 
SARA 302 COMPONENTS 
SARA 302: No chemicals in this material are subject to the reporting requirements of SARA Title 
III, Section 302 
SARA 313 COMPONENTS 
SARA 313: This material does not contain any chemical components with known CAS numbers 
that exceed threshold (De Minimis) reporting levels establi shed be SARA Title III, Section 313 
SARA 311/312 HAZARDS 
Acute health hazards, chronic health hazards , fire hazard 
MASSACHUSETTS RIGHT TO KNOW COMPONENTS 
CAS-No. Revision Date 
Glycerol 56-81-5 2007-03-01 
PENNSYVANIA RIGHT TO KNOW COMPONENTS 
CAS-No. Revision Date 
L-α-PHOSPHATIDYLCHOLINE, hydrogenated 97281-48-6 1989-08-11 
Glycerol 56-81-5 2007-03-01 
Butane-1,3-diol 107-88-0 
Water 7732-18-5 
Resveratrol 501-36-0 
NEW JERSEY RIGHT TO KNOW COMPONENTS 
CAS-No. Revision Date 
L-α-PHOSPHATIDYLCHOLINE, hydrogenated 97281-48-6 1989-08-11 
Glycerol 56-81-5 2007-03-01 
Butane-1,3-diol 107-88-0 
Water 7732-18-5 
Resveratrol 501-36-0
Material Safety Data Sheet 
Version 1.1 
Revision Date: 06/05/2014 
Print Date: 08/06/2014 
CALIFORNIA PROP. 65 COMPONENTS 
CAS-No. Revision Date 
L-α-PHOSPHATIDYLCHOLINE, hydrogenated 97281-48-6 1989-08-11 
U.S Department of Homeland Security 
This product does not contain any DHS chemicals 
Canada 
This product has been classified in accordance with the hazard criteria of the Controlled Products 
Regulation (CPR) and the MSDS contains all the information required by the CPR. 
CAS# 7732185 is listed on Canada's DSL List 
TSCA 
CAS# 7732185 is listed on the TSCA Inventory 
16. OTHER INFORMATION 
Copyright 2013 Encapsula NanoSciences LLC license granted to make unlimited paper copies for internal 
use only. 
The above information is believed to be correct but does not support to be all inclusive and shall be used 
only as a guide. The information in this document is based on the present state of our knowledge and is 
applicable to the product with regard to appropriate safety precautions. It does not represent any 
guarantee of the properties of the product. Encapsula NanoSciences LLC shall not be held liable for any 
damage resulting from handling or from contact with the above product.

Más contenido relacionado

La actualidad más candente

MSDS Dermasome-ACE (NE, not containing ethanol)
MSDS Dermasome-ACE (NE, not containing ethanol)MSDS Dermasome-ACE (NE, not containing ethanol)
MSDS Dermasome-ACE (NE, not containing ethanol)Encapsula NanoSciences
 
MSDS for Doxorubicin Solution used for Remoted Loading of Non-PEGylated lipos...
MSDS for Doxorubicin Solution used for Remoted Loading of Non-PEGylated lipos...MSDS for Doxorubicin Solution used for Remoted Loading of Non-PEGylated lipos...
MSDS for Doxorubicin Solution used for Remoted Loading of Non-PEGylated lipos...Encapsula NanoSciences
 
MSDS for Doxorubicin Solution used for Remote Loading of Non-PEGylated liposo...
MSDS for Doxorubicin Solution used for Remote Loading of Non-PEGylated liposo...MSDS for Doxorubicin Solution used for Remote Loading of Non-PEGylated liposo...
MSDS for Doxorubicin Solution used for Remote Loading of Non-PEGylated liposo...Encapsula NanoSciences
 
MSDS Cosmesome-ACE (NE, not containing ethanol)
MSDS Cosmesome-ACE (NE, not containing ethanol)MSDS Cosmesome-ACE (NE, not containing ethanol)
MSDS Cosmesome-ACE (NE, not containing ethanol)Encapsula NanoSciences
 
MSDS Dermasome-Ubq (NE, not containing ethanol)
MSDS Dermasome-Ubq (NE, not containing ethanol)MSDS Dermasome-Ubq (NE, not containing ethanol)
MSDS Dermasome-Ubq (NE, not containing ethanol)Encapsula NanoSciences
 
MSDS for PEGylated liposomal Doxorubicin containing PDP lipid for conjugation...
MSDS for PEGylated liposomal Doxorubicin containing PDP lipid for conjugation...MSDS for PEGylated liposomal Doxorubicin containing PDP lipid for conjugation...
MSDS for PEGylated liposomal Doxorubicin containing PDP lipid for conjugation...Encapsula NanoSciences
 
MSDS for PEGylated liposomal Doxorubicin containing cyanur reactive lipid for...
MSDS for PEGylated liposomal Doxorubicin containing cyanur reactive lipid for...MSDS for PEGylated liposomal Doxorubicin containing cyanur reactive lipid for...
MSDS for PEGylated liposomal Doxorubicin containing cyanur reactive lipid for...Encapsula NanoSciences
 
MSDS for PEGylated liposomal Doxorubicin containing amine reactive lipid for ...
MSDS for PEGylated liposomal Doxorubicin containing amine reactive lipid for ...MSDS for PEGylated liposomal Doxorubicin containing amine reactive lipid for ...
MSDS for PEGylated liposomal Doxorubicin containing amine reactive lipid for ...Encapsula NanoSciences
 
MSDS for PEGylated liposomal Doxorubicin containing aldehyde reactive lipid f...
MSDS for PEGylated liposomal Doxorubicin containing aldehyde reactive lipid f...MSDS for PEGylated liposomal Doxorubicin containing aldehyde reactive lipid f...
MSDS for PEGylated liposomal Doxorubicin containing aldehyde reactive lipid f...Encapsula NanoSciences
 
MSDS for PEGylated liposomal Doxorubicin containing folate lipid _IMMUNODOX_f...
MSDS for PEGylated liposomal Doxorubicin containing folate lipid _IMMUNODOX_f...MSDS for PEGylated liposomal Doxorubicin containing folate lipid _IMMUNODOX_f...
MSDS for PEGylated liposomal Doxorubicin containing folate lipid _IMMUNODOX_f...Encapsula NanoSciences
 
MSDS for PEGylated liposomal Doxorubicin containing DBCO lipid for conjugatio...
MSDS for PEGylated liposomal Doxorubicin containing DBCO lipid for conjugatio...MSDS for PEGylated liposomal Doxorubicin containing DBCO lipid for conjugatio...
MSDS for PEGylated liposomal Doxorubicin containing DBCO lipid for conjugatio...Encapsula NanoSciences
 
MSDS for PEGylated liposomal Doxorubicin containing azide lipid for conjugati...
MSDS for PEGylated liposomal Doxorubicin containing azide lipid for conjugati...MSDS for PEGylated liposomal Doxorubicin containing azide lipid for conjugati...
MSDS for PEGylated liposomal Doxorubicin containing azide lipid for conjugati...Encapsula NanoSciences
 
MSDS for PEGylated liposomal Doxorubicin_Doxosome
MSDS for PEGylated liposomal Doxorubicin_DoxosomeMSDS for PEGylated liposomal Doxorubicin_Doxosome
MSDS for PEGylated liposomal Doxorubicin_DoxosomeEncapsula NanoSciences
 
MSDS Cosmesome (NE, Not containing ethanol)
MSDS Cosmesome (NE, Not containing ethanol)MSDS Cosmesome (NE, Not containing ethanol)
MSDS Cosmesome (NE, Not containing ethanol)Encapsula NanoSciences
 
MSDS for PEGylated liposomal Doxorubicin containing biotin lipid for conjugat...
MSDS for PEGylated liposomal Doxorubicin containing biotin lipid for conjugat...MSDS for PEGylated liposomal Doxorubicin containing biotin lipid for conjugat...
MSDS for PEGylated liposomal Doxorubicin containing biotin lipid for conjugat...Encapsula NanoSciences
 
MSDS for PEGylated control liposomes containing Biotin lipid for conjugation_...
MSDS for PEGylated control liposomes containing Biotin lipid for conjugation_...MSDS for PEGylated control liposomes containing Biotin lipid for conjugation_...
MSDS for PEGylated control liposomes containing Biotin lipid for conjugation_...Encapsula NanoSciences
 

La actualidad más candente (20)

MSDS Dermasome-ACE (NE, not containing ethanol)
MSDS Dermasome-ACE (NE, not containing ethanol)MSDS Dermasome-ACE (NE, not containing ethanol)
MSDS Dermasome-ACE (NE, not containing ethanol)
 
MSDS for Doxorubicin Solution used for Remoted Loading of Non-PEGylated lipos...
MSDS for Doxorubicin Solution used for Remoted Loading of Non-PEGylated lipos...MSDS for Doxorubicin Solution used for Remoted Loading of Non-PEGylated lipos...
MSDS for Doxorubicin Solution used for Remoted Loading of Non-PEGylated lipos...
 
MSDS for Doxorubicin Solution used for Remote Loading of Non-PEGylated liposo...
MSDS for Doxorubicin Solution used for Remote Loading of Non-PEGylated liposo...MSDS for Doxorubicin Solution used for Remote Loading of Non-PEGylated liposo...
MSDS for Doxorubicin Solution used for Remote Loading of Non-PEGylated liposo...
 
MSDS DermaMix-Chol
MSDS DermaMix-Chol MSDS DermaMix-Chol
MSDS DermaMix-Chol
 
MSDS Cosmesome-ACE (NE, not containing ethanol)
MSDS Cosmesome-ACE (NE, not containing ethanol)MSDS Cosmesome-ACE (NE, not containing ethanol)
MSDS Cosmesome-ACE (NE, not containing ethanol)
 
MSDS Dermasome-Ubq (NE, not containing ethanol)
MSDS Dermasome-Ubq (NE, not containing ethanol)MSDS Dermasome-Ubq (NE, not containing ethanol)
MSDS Dermasome-Ubq (NE, not containing ethanol)
 
MSDS Dermasome Conatining Alcohol
MSDS Dermasome Conatining Alcohol MSDS Dermasome Conatining Alcohol
MSDS Dermasome Conatining Alcohol
 
MSDS for PEGylated liposomal Doxorubicin containing PDP lipid for conjugation...
MSDS for PEGylated liposomal Doxorubicin containing PDP lipid for conjugation...MSDS for PEGylated liposomal Doxorubicin containing PDP lipid for conjugation...
MSDS for PEGylated liposomal Doxorubicin containing PDP lipid for conjugation...
 
MSDS for PEGylated liposomal Doxorubicin containing cyanur reactive lipid for...
MSDS for PEGylated liposomal Doxorubicin containing cyanur reactive lipid for...MSDS for PEGylated liposomal Doxorubicin containing cyanur reactive lipid for...
MSDS for PEGylated liposomal Doxorubicin containing cyanur reactive lipid for...
 
MSDS for PEGylated liposomal Doxorubicin containing amine reactive lipid for ...
MSDS for PEGylated liposomal Doxorubicin containing amine reactive lipid for ...MSDS for PEGylated liposomal Doxorubicin containing amine reactive lipid for ...
MSDS for PEGylated liposomal Doxorubicin containing amine reactive lipid for ...
 
MSDS for PEGylated liposomal Doxorubicin containing aldehyde reactive lipid f...
MSDS for PEGylated liposomal Doxorubicin containing aldehyde reactive lipid f...MSDS for PEGylated liposomal Doxorubicin containing aldehyde reactive lipid f...
MSDS for PEGylated liposomal Doxorubicin containing aldehyde reactive lipid f...
 
MSDS for PEGylated liposomal Doxorubicin containing folate lipid _IMMUNODOX_f...
MSDS for PEGylated liposomal Doxorubicin containing folate lipid _IMMUNODOX_f...MSDS for PEGylated liposomal Doxorubicin containing folate lipid _IMMUNODOX_f...
MSDS for PEGylated liposomal Doxorubicin containing folate lipid _IMMUNODOX_f...
 
MSDS Cosmesome-Ubq Containing Alcohol
MSDS Cosmesome-Ubq Containing AlcoholMSDS Cosmesome-Ubq Containing Alcohol
MSDS Cosmesome-Ubq Containing Alcohol
 
MSDS for PEGylated liposomal Doxorubicin containing DBCO lipid for conjugatio...
MSDS for PEGylated liposomal Doxorubicin containing DBCO lipid for conjugatio...MSDS for PEGylated liposomal Doxorubicin containing DBCO lipid for conjugatio...
MSDS for PEGylated liposomal Doxorubicin containing DBCO lipid for conjugatio...
 
MSDS for PEGylated liposomal Doxorubicin containing azide lipid for conjugati...
MSDS for PEGylated liposomal Doxorubicin containing azide lipid for conjugati...MSDS for PEGylated liposomal Doxorubicin containing azide lipid for conjugati...
MSDS for PEGylated liposomal Doxorubicin containing azide lipid for conjugati...
 
MSDS for PEGylated liposomal Doxorubicin_Doxosome
MSDS for PEGylated liposomal Doxorubicin_DoxosomeMSDS for PEGylated liposomal Doxorubicin_Doxosome
MSDS for PEGylated liposomal Doxorubicin_Doxosome
 
MSDS Cosmesome (NE, Not containing ethanol)
MSDS Cosmesome (NE, Not containing ethanol)MSDS Cosmesome (NE, Not containing ethanol)
MSDS Cosmesome (NE, Not containing ethanol)
 
MSDS Cosmesome Containing Alcohol
MSDS Cosmesome Containing AlcoholMSDS Cosmesome Containing Alcohol
MSDS Cosmesome Containing Alcohol
 
MSDS for PEGylated liposomal Doxorubicin containing biotin lipid for conjugat...
MSDS for PEGylated liposomal Doxorubicin containing biotin lipid for conjugat...MSDS for PEGylated liposomal Doxorubicin containing biotin lipid for conjugat...
MSDS for PEGylated liposomal Doxorubicin containing biotin lipid for conjugat...
 
MSDS for PEGylated control liposomes containing Biotin lipid for conjugation_...
MSDS for PEGylated control liposomes containing Biotin lipid for conjugation_...MSDS for PEGylated control liposomes containing Biotin lipid for conjugation_...
MSDS for PEGylated control liposomes containing Biotin lipid for conjugation_...
 

Similar a MSDS Cosmesome-Res (NE, not containing ethanol)

MSDS Cosmesome-Res Containing Alcohol
MSDS Cosmesome-Res Containing Alcohol MSDS Cosmesome-Res Containing Alcohol
MSDS Cosmesome-Res Containing Alcohol Encapsula NanoSciences
 
MSDS for PEGylated liposomal Doxorubicin containing maleimide reactive lipid ...
MSDS for PEGylated liposomal Doxorubicin containing maleimide reactive lipid ...MSDS for PEGylated liposomal Doxorubicin containing maleimide reactive lipid ...
MSDS for PEGylated liposomal Doxorubicin containing maleimide reactive lipid ...Encapsula NanoSciences
 
MSDS for PEGylated liposomal Doxorubicin containing NHS reactive lipid for co...
MSDS for PEGylated liposomal Doxorubicin containing NHS reactive lipid for co...MSDS for PEGylated liposomal Doxorubicin containing NHS reactive lipid for co...
MSDS for PEGylated liposomal Doxorubicin containing NHS reactive lipid for co...Encapsula NanoSciences
 
MSDS Dermasome (NE, not containing ethanol)
MSDS Dermasome (NE, not containing ethanol)MSDS Dermasome (NE, not containing ethanol)
MSDS Dermasome (NE, not containing ethanol)Encapsula NanoSciences
 
MSDS Cosmesome-Chol Containing Alcohol
MSDS Cosmesome-Chol Containing AlcoholMSDS Cosmesome-Chol Containing Alcohol
MSDS Cosmesome-Chol Containing AlcoholEncapsula NanoSciences
 
MSDS Dermasome-Chol Containing Alcohol
MSDS Dermasome-Chol Containing Alcohol MSDS Dermasome-Chol Containing Alcohol
MSDS Dermasome-Chol Containing Alcohol Encapsula NanoSciences
 
MSDS for PEGylated liposomal Doxorubicin containing carboxylic acid reactive ...
MSDS for PEGylated liposomal Doxorubicin containing carboxylic acid reactive ...MSDS for PEGylated liposomal Doxorubicin containing carboxylic acid reactive ...
MSDS for PEGylated liposomal Doxorubicin containing carboxylic acid reactive ...Encapsula NanoSciences
 
MSDS for PEGylated liposomal Doxorubicin containing succinyl reactive lipid f...
MSDS for PEGylated liposomal Doxorubicin containing succinyl reactive lipid f...MSDS for PEGylated liposomal Doxorubicin containing succinyl reactive lipid f...
MSDS for PEGylated liposomal Doxorubicin containing succinyl reactive lipid f...Encapsula NanoSciences
 
MSDS for Non-PEGylated liposomes containing Biotinyl lipid for conjugation_IM...
MSDS for Non-PEGylated liposomes containing Biotinyl lipid for conjugation_IM...MSDS for Non-PEGylated liposomes containing Biotinyl lipid for conjugation_IM...
MSDS for Non-PEGylated liposomes containing Biotinyl lipid for conjugation_IM...Encapsula NanoSciences
 
MSDS for Non-PEGylated liposomes containing NHS lipid for conjugation_IMMUNOD...
MSDS for Non-PEGylated liposomes containing NHS lipid for conjugation_IMMUNOD...MSDS for Non-PEGylated liposomes containing NHS lipid for conjugation_IMMUNOD...
MSDS for Non-PEGylated liposomes containing NHS lipid for conjugation_IMMUNOD...Encapsula NanoSciences
 

Similar a MSDS Cosmesome-Res (NE, not containing ethanol) (13)

MSDS Cosmesome-Res Containing Alcohol
MSDS Cosmesome-Res Containing Alcohol MSDS Cosmesome-Res Containing Alcohol
MSDS Cosmesome-Res Containing Alcohol
 
MSDS for PEGylated liposomal Doxorubicin containing maleimide reactive lipid ...
MSDS for PEGylated liposomal Doxorubicin containing maleimide reactive lipid ...MSDS for PEGylated liposomal Doxorubicin containing maleimide reactive lipid ...
MSDS for PEGylated liposomal Doxorubicin containing maleimide reactive lipid ...
 
MSDS for PEGylated liposomal Doxorubicin containing NHS reactive lipid for co...
MSDS for PEGylated liposomal Doxorubicin containing NHS reactive lipid for co...MSDS for PEGylated liposomal Doxorubicin containing NHS reactive lipid for co...
MSDS for PEGylated liposomal Doxorubicin containing NHS reactive lipid for co...
 
MSDS Dermasome-Ubq Containing Alcohol
MSDS Dermasome-Ubq Containing AlcoholMSDS Dermasome-Ubq Containing Alcohol
MSDS Dermasome-Ubq Containing Alcohol
 
MSDS Dermasome (NE, not containing ethanol)
MSDS Dermasome (NE, not containing ethanol)MSDS Dermasome (NE, not containing ethanol)
MSDS Dermasome (NE, not containing ethanol)
 
MSDS Cosmesome-Chol Containing Alcohol
MSDS Cosmesome-Chol Containing AlcoholMSDS Cosmesome-Chol Containing Alcohol
MSDS Cosmesome-Chol Containing Alcohol
 
MSDS CosmoMix-ACE
MSDS CosmoMix-ACE MSDS CosmoMix-ACE
MSDS CosmoMix-ACE
 
MSDS Dermasome-Res Containing Alcohol
MSDS Dermasome-Res Containing AlcoholMSDS Dermasome-Res Containing Alcohol
MSDS Dermasome-Res Containing Alcohol
 
MSDS Dermasome-Chol Containing Alcohol
MSDS Dermasome-Chol Containing Alcohol MSDS Dermasome-Chol Containing Alcohol
MSDS Dermasome-Chol Containing Alcohol
 
MSDS for PEGylated liposomal Doxorubicin containing carboxylic acid reactive ...
MSDS for PEGylated liposomal Doxorubicin containing carboxylic acid reactive ...MSDS for PEGylated liposomal Doxorubicin containing carboxylic acid reactive ...
MSDS for PEGylated liposomal Doxorubicin containing carboxylic acid reactive ...
 
MSDS for PEGylated liposomal Doxorubicin containing succinyl reactive lipid f...
MSDS for PEGylated liposomal Doxorubicin containing succinyl reactive lipid f...MSDS for PEGylated liposomal Doxorubicin containing succinyl reactive lipid f...
MSDS for PEGylated liposomal Doxorubicin containing succinyl reactive lipid f...
 
MSDS for Non-PEGylated liposomes containing Biotinyl lipid for conjugation_IM...
MSDS for Non-PEGylated liposomes containing Biotinyl lipid for conjugation_IM...MSDS for Non-PEGylated liposomes containing Biotinyl lipid for conjugation_IM...
MSDS for Non-PEGylated liposomes containing Biotinyl lipid for conjugation_IM...
 
MSDS for Non-PEGylated liposomes containing NHS lipid for conjugation_IMMUNOD...
MSDS for Non-PEGylated liposomes containing NHS lipid for conjugation_IMMUNOD...MSDS for Non-PEGylated liposomes containing NHS lipid for conjugation_IMMUNOD...
MSDS for Non-PEGylated liposomes containing NHS lipid for conjugation_IMMUNOD...
 

Más de Encapsula NanoSciences

Más de Encapsula NanoSciences (13)

SDS for Clodrosome® by Encapsula NanoSciences
SDS for Clodrosome® by Encapsula NanoSciencesSDS for Clodrosome® by Encapsula NanoSciences
SDS for Clodrosome® by Encapsula NanoSciences
 
Product Spec Sheet DermaMix-ACE
Product Spec Sheet DermaMix-ACEProduct Spec Sheet DermaMix-ACE
Product Spec Sheet DermaMix-ACE
 
Product Spec Sheet DermaMix-Ubq
Product Spec Sheet DermaMix-UbqProduct Spec Sheet DermaMix-Ubq
Product Spec Sheet DermaMix-Ubq
 
Product Spec Sheet DermaMix-Res
Product Spec Sheet DermaMix-ResProduct Spec Sheet DermaMix-Res
Product Spec Sheet DermaMix-Res
 
Product Spec Sheet DermaMix-Chol
Product Spec Sheet DermaMix-CholProduct Spec Sheet DermaMix-Chol
Product Spec Sheet DermaMix-Chol
 
Spec sheets derma mix - ace
Spec sheets derma mix - aceSpec sheets derma mix - ace
Spec sheets derma mix - ace
 
Product Spec Sheet CosmoMix-Ubq
Product Spec Sheet CosmoMix-UbqProduct Spec Sheet CosmoMix-Ubq
Product Spec Sheet CosmoMix-Ubq
 
Product Spec Sheet CosmoMix-Res
Product Spec Sheet CosmoMix-ResProduct Spec Sheet CosmoMix-Res
Product Spec Sheet CosmoMix-Res
 
Product Spec Sheet CosmoMix-Chol
Product Spec Sheet CosmoMix-CholProduct Spec Sheet CosmoMix-Chol
Product Spec Sheet CosmoMix-Chol
 
Product Spec Sheet CosmoMix-ACE
Product Spec Sheet CosmoMix-ACEProduct Spec Sheet CosmoMix-ACE
Product Spec Sheet CosmoMix-ACE
 
Product Spec Sheet Spec sheets cosmesome
Product Spec Sheet Spec sheets cosmesomeProduct Spec Sheet Spec sheets cosmesome
Product Spec Sheet Spec sheets cosmesome
 
MSDS DermaMix-ACE
MSDS DermaMix-ACEMSDS DermaMix-ACE
MSDS DermaMix-ACE
 
MSDS Dermasome-ACE Containing Alcohol
MSDS Dermasome-ACE Containing Alcohol MSDS Dermasome-ACE Containing Alcohol
MSDS Dermasome-ACE Containing Alcohol
 

Último

GENERAL PHYSICS 2 REFRACTION OF LIGHT SENIOR HIGH SCHOOL GENPHYS2.pptx
GENERAL PHYSICS 2 REFRACTION OF LIGHT SENIOR HIGH SCHOOL GENPHYS2.pptxGENERAL PHYSICS 2 REFRACTION OF LIGHT SENIOR HIGH SCHOOL GENPHYS2.pptx
GENERAL PHYSICS 2 REFRACTION OF LIGHT SENIOR HIGH SCHOOL GENPHYS2.pptxRitchAndruAgustin
 
BACTERIAL DEFENSE SYSTEM by Dr. Chayanika Das
BACTERIAL DEFENSE SYSTEM by Dr. Chayanika DasBACTERIAL DEFENSE SYSTEM by Dr. Chayanika Das
BACTERIAL DEFENSE SYSTEM by Dr. Chayanika DasChayanika Das
 
linear Regression, multiple Regression and Annova
linear Regression, multiple Regression and Annovalinear Regression, multiple Regression and Annova
linear Regression, multiple Regression and AnnovaMansi Rastogi
 
Introduction of Human Body & Structure of cell.pptx
Introduction of Human Body & Structure of cell.pptxIntroduction of Human Body & Structure of cell.pptx
Introduction of Human Body & Structure of cell.pptxMedical College
 
Pests of Sunflower_Binomics_Identification_Dr.UPR
Pests of Sunflower_Binomics_Identification_Dr.UPRPests of Sunflower_Binomics_Identification_Dr.UPR
Pests of Sunflower_Binomics_Identification_Dr.UPRPirithiRaju
 
Observational constraints on mergers creating magnetism in massive stars
Observational constraints on mergers creating magnetism in massive starsObservational constraints on mergers creating magnetism in massive stars
Observational constraints on mergers creating magnetism in massive starsSérgio Sacani
 
Charateristics of the Angara-A5 spacecraft launched from the Vostochny Cosmod...
Charateristics of the Angara-A5 spacecraft launched from the Vostochny Cosmod...Charateristics of the Angara-A5 spacecraft launched from the Vostochny Cosmod...
Charateristics of the Angara-A5 spacecraft launched from the Vostochny Cosmod...Christina Parmionova
 
complex analysis best book for solving questions.pdf
complex analysis best book for solving questions.pdfcomplex analysis best book for solving questions.pdf
complex analysis best book for solving questions.pdfSubhamKumar3239
 
DETECTION OF MUTATION BY CLB METHOD.pptx
DETECTION OF MUTATION BY CLB METHOD.pptxDETECTION OF MUTATION BY CLB METHOD.pptx
DETECTION OF MUTATION BY CLB METHOD.pptx201bo007
 
Advances in AI-driven Image Recognition for Early Detection of Cancer
Advances in AI-driven Image Recognition for Early Detection of CancerAdvances in AI-driven Image Recognition for Early Detection of Cancer
Advances in AI-driven Image Recognition for Early Detection of CancerLuis Miguel Chong Chong
 
FBI Profiling - Forensic Psychology.pptx
FBI Profiling - Forensic Psychology.pptxFBI Profiling - Forensic Psychology.pptx
FBI Profiling - Forensic Psychology.pptxPayal Shrivastava
 
WEEK 4 PHYSICAL SCIENCE QUARTER 3 FOR G11
WEEK 4 PHYSICAL SCIENCE QUARTER 3 FOR G11WEEK 4 PHYSICAL SCIENCE QUARTER 3 FOR G11
WEEK 4 PHYSICAL SCIENCE QUARTER 3 FOR G11GelineAvendao
 
CHROMATOGRAPHY PALLAVI RAWAT.pptx
CHROMATOGRAPHY  PALLAVI RAWAT.pptxCHROMATOGRAPHY  PALLAVI RAWAT.pptx
CHROMATOGRAPHY PALLAVI RAWAT.pptxpallavirawat456
 
cybrids.pptx production_advanges_limitation
cybrids.pptx production_advanges_limitationcybrids.pptx production_advanges_limitation
cybrids.pptx production_advanges_limitationSanghamitraMohapatra5
 
whole genome sequencing new and its types including shortgun and clone by clone
whole genome sequencing new  and its types including shortgun and clone by clonewhole genome sequencing new  and its types including shortgun and clone by clone
whole genome sequencing new and its types including shortgun and clone by clonechaudhary charan shingh university
 
Oxo-Acids of Halogens and their Salts.pptx
Oxo-Acids of Halogens and their Salts.pptxOxo-Acids of Halogens and their Salts.pptx
Oxo-Acids of Halogens and their Salts.pptxfarhanvvdk
 
Measures of Central Tendency.pptx for UG
Measures of Central Tendency.pptx for UGMeasures of Central Tendency.pptx for UG
Measures of Central Tendency.pptx for UGSoniaBajaj10
 
GenAI talk for Young at Wageningen University & Research (WUR) March 2024
GenAI talk for Young at Wageningen University & Research (WUR) March 2024GenAI talk for Young at Wageningen University & Research (WUR) March 2024
GenAI talk for Young at Wageningen University & Research (WUR) March 2024Jene van der Heide
 
Q4-Mod-1c-Quiz-Projectile-333344444.pptx
Q4-Mod-1c-Quiz-Projectile-333344444.pptxQ4-Mod-1c-Quiz-Projectile-333344444.pptx
Q4-Mod-1c-Quiz-Projectile-333344444.pptxtuking87
 

Último (20)

GENERAL PHYSICS 2 REFRACTION OF LIGHT SENIOR HIGH SCHOOL GENPHYS2.pptx
GENERAL PHYSICS 2 REFRACTION OF LIGHT SENIOR HIGH SCHOOL GENPHYS2.pptxGENERAL PHYSICS 2 REFRACTION OF LIGHT SENIOR HIGH SCHOOL GENPHYS2.pptx
GENERAL PHYSICS 2 REFRACTION OF LIGHT SENIOR HIGH SCHOOL GENPHYS2.pptx
 
BACTERIAL DEFENSE SYSTEM by Dr. Chayanika Das
BACTERIAL DEFENSE SYSTEM by Dr. Chayanika DasBACTERIAL DEFENSE SYSTEM by Dr. Chayanika Das
BACTERIAL DEFENSE SYSTEM by Dr. Chayanika Das
 
linear Regression, multiple Regression and Annova
linear Regression, multiple Regression and Annovalinear Regression, multiple Regression and Annova
linear Regression, multiple Regression and Annova
 
Introduction of Human Body & Structure of cell.pptx
Introduction of Human Body & Structure of cell.pptxIntroduction of Human Body & Structure of cell.pptx
Introduction of Human Body & Structure of cell.pptx
 
Pests of Sunflower_Binomics_Identification_Dr.UPR
Pests of Sunflower_Binomics_Identification_Dr.UPRPests of Sunflower_Binomics_Identification_Dr.UPR
Pests of Sunflower_Binomics_Identification_Dr.UPR
 
Observational constraints on mergers creating magnetism in massive stars
Observational constraints on mergers creating magnetism in massive starsObservational constraints on mergers creating magnetism in massive stars
Observational constraints on mergers creating magnetism in massive stars
 
Charateristics of the Angara-A5 spacecraft launched from the Vostochny Cosmod...
Charateristics of the Angara-A5 spacecraft launched from the Vostochny Cosmod...Charateristics of the Angara-A5 spacecraft launched from the Vostochny Cosmod...
Charateristics of the Angara-A5 spacecraft launched from the Vostochny Cosmod...
 
complex analysis best book for solving questions.pdf
complex analysis best book for solving questions.pdfcomplex analysis best book for solving questions.pdf
complex analysis best book for solving questions.pdf
 
DETECTION OF MUTATION BY CLB METHOD.pptx
DETECTION OF MUTATION BY CLB METHOD.pptxDETECTION OF MUTATION BY CLB METHOD.pptx
DETECTION OF MUTATION BY CLB METHOD.pptx
 
Advances in AI-driven Image Recognition for Early Detection of Cancer
Advances in AI-driven Image Recognition for Early Detection of CancerAdvances in AI-driven Image Recognition for Early Detection of Cancer
Advances in AI-driven Image Recognition for Early Detection of Cancer
 
FBI Profiling - Forensic Psychology.pptx
FBI Profiling - Forensic Psychology.pptxFBI Profiling - Forensic Psychology.pptx
FBI Profiling - Forensic Psychology.pptx
 
WEEK 4 PHYSICAL SCIENCE QUARTER 3 FOR G11
WEEK 4 PHYSICAL SCIENCE QUARTER 3 FOR G11WEEK 4 PHYSICAL SCIENCE QUARTER 3 FOR G11
WEEK 4 PHYSICAL SCIENCE QUARTER 3 FOR G11
 
CHROMATOGRAPHY PALLAVI RAWAT.pptx
CHROMATOGRAPHY  PALLAVI RAWAT.pptxCHROMATOGRAPHY  PALLAVI RAWAT.pptx
CHROMATOGRAPHY PALLAVI RAWAT.pptx
 
cybrids.pptx production_advanges_limitation
cybrids.pptx production_advanges_limitationcybrids.pptx production_advanges_limitation
cybrids.pptx production_advanges_limitation
 
whole genome sequencing new and its types including shortgun and clone by clone
whole genome sequencing new  and its types including shortgun and clone by clonewhole genome sequencing new  and its types including shortgun and clone by clone
whole genome sequencing new and its types including shortgun and clone by clone
 
Introduction Classification Of Alkaloids
Introduction Classification Of AlkaloidsIntroduction Classification Of Alkaloids
Introduction Classification Of Alkaloids
 
Oxo-Acids of Halogens and their Salts.pptx
Oxo-Acids of Halogens and their Salts.pptxOxo-Acids of Halogens and their Salts.pptx
Oxo-Acids of Halogens and their Salts.pptx
 
Measures of Central Tendency.pptx for UG
Measures of Central Tendency.pptx for UGMeasures of Central Tendency.pptx for UG
Measures of Central Tendency.pptx for UG
 
GenAI talk for Young at Wageningen University & Research (WUR) March 2024
GenAI talk for Young at Wageningen University & Research (WUR) March 2024GenAI talk for Young at Wageningen University & Research (WUR) March 2024
GenAI talk for Young at Wageningen University & Research (WUR) March 2024
 
Q4-Mod-1c-Quiz-Projectile-333344444.pptx
Q4-Mod-1c-Quiz-Projectile-333344444.pptxQ4-Mod-1c-Quiz-Projectile-333344444.pptx
Q4-Mod-1c-Quiz-Projectile-333344444.pptx
 

MSDS Cosmesome-Res (NE, not containing ethanol)

  • 1. Material Safety Data Sheet Version 1.1 Revision Date: 06/05/2014 Print Date: 08/06/2014 1. PRODUCT AND COMPANY IDENTIFICATION Product name: COSMESOME TM- Res (NE) Product Number: COS-1009 Brand: COSMESOME TM Company Address: ENCAPSULA NANOSCIENCES LLC 6 CADILLAC DRIVE SUITE 245 BRENTWOOD, TN, 37027 Technical Phone: 615-884-4442 Fax: 615-250-8747 Emergency Phone: 615-438-8553 CHEMTREC: 1-800-424-9300 2. COMPOSITION/INFORMATION ON INGREDIENTS Ingredient Name CAS# Percent WATER 7732-18-5 >90 GLYCERIN 56-81-5 1, 3 Butanediol 107-88-0 <5 3,5,4-TRIHYHROXY-TRANS-STILBENE 501-36-0 L-α-PHOSPHATIDYLCHOLINE, hydrogenated 97281-48-6 <5 3. HAZARDS IDENTIFCATION OSHA No known OSHA hazards TARGET ORGANS Skin, Respiratory, Eyes WHMIS HAZARD CLASS D1B toxic materials D2B toxic materials HMIS RATING HEALTH HAZARDS: 1 FLAMMABILITY: 1 CHRONIC HEALTH HAZARDS: * PHYSICAL HAZARDS: 0
  • 2. Material Safety Data Sheet Version 1.1 Revision Date: 06/05/2014 Print Date: 08/06/2014 NFPA RATING HEALTH HAZARD: 2 FLAMMABILTY: 1 REACTIVITY: 0 POTENTIAL HEALTH EFFECTS Inhalation May be harmful if inhaled. Skin May be harmful if absorbed through skin Eyes May cause eye irritation. Ingestion May be harmful if swallowed. Chronic No existing conditions have been investigated 4. FIRST AID MEASURES ORAL EXPOSURE Do not induce vomiting. Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician INHALATION EXPOSURE If inhaled, remove to fresh air. If not breathing give artificial respiration. If breathing is difficult, give oxygen. Do not use mouth to mouth resuscitation. Consult a physician. DERMAL EXPOSURE In case of contact, immediately wash skin with soap and copious amounts of water. Cover skin with an emollient. Contact a physician. EYE EXPOSURE In case of contact, check or remove any contact lenses; immediately flush eyes with copious amounts of water for at least 15 minutes. Contact a physician. 5. FIRE FIGHTING MEASURES FLAMMABILITY Not available EXTINGUISHING MEDIA It is suitable to use water spray, alcohol -resistant foam, dry chemical or carbon dioxide.
  • 3. Material Safety Data Sheet Version 1.1 Revision Date: 06/05/2014 Print Date: 08/06/2014 SPECIAL PROCTECTIVE EQUIPMENT FOR FIRE-FIGHTERS Wear self-contained breathing apparatus and protective clothing to prevent contact with skin and eyes. Included a positive pressure NIOSH approved self-contained breathing apparatus. HAZARDOUS COMBUSTION PRODUCTS Carbon oxides SPECIAL REMARKS Not available ACCIDENTAL RELEASE MEASURES METHODS FOR CLEANING UP Soak up inert absorbent material and dispose of as waste. Keep in suitable container for disposal. Use appropriate tools to put this spilled solid in a convenient waste disposable container and finish cleaning by spreading water on the contaminated surface and dispose of according to local and region authority requirements. Allow to evacuate through the sanitary system ENVIRONMENTAL PRECAUTIONS Do not let product enter drains. If safe to do so prevent further leakages or spills. PERSONAL PRECAUTIONS Use personal protective equipment. Avoid breathing in vapors, mist or gas. Ensure adequate ventilation. Prepare evacuation sites. 6. HANDLING AND STORAGE HANDLING User Exposure: Do not breathe vapor, dust, fume, gas, mist and spray. Avoid prolonged or repeated exposure. Do not get in eyes, on skin, on clothing. Wash hands thoroughly after handling. STORAGE Suitable: Keep tightly container closed. Store in temperature between approximately 2-8 o C. Do not freeze keep in refrigerator. Product is sensitive to moisture and light. Keep product and empty container away from heat and sources ignition. 7. EXPOSURE CONTROLS/ PERSONAL PROTECTION ENGINEERING CONTROLS Safety shower and eye bath. Mechanical exhaust required.
  • 4. Material Safety Data Sheet Version 1.1 Revision Date: 06/05/2014 Print Date: 08/06/2014 PERSONAL PROTECTIVE EQUIPMENT Respiratory: Use respirators and components tested and approved under appropriate government standards such as NIOSH (US) in accord with 29 CFR 1910.134 or EN 149, use either an atmosphere supply respirator or air purifying respirator. Also follow face protection regulations in 29 CFR 1910.133 or European standard EN 166. Also use a full -face respirator with multi -purpose combination (US) or type ABEK (EN 14387) respirator cartridges as a back up to engineering controls. If the respirator is the sole means of protection, use a full -face supplied airs respirator. Use respirators and components tested and approved under appropriate government standers such as NIOSH (US) or CEN (EU). Hand: Compatible chemical -resistant gloves. Eye: Chemical safety goggles. Safety glasses with side-shields conforming to EN 166 use equipment for eye protection listed and approved under appropriated government standards such as NIOSH (US) or EN166 (EU) Skin and Body: Wear a complete suit protecting against chemicals. GENERAL HYGIENE MEASURES Wash hands thoroughly after handling. Wash contaminated clothing before reuse. Prepare all materials under the fume hood and avoid generating aerosols. 8. PHYSICAL AND CHEMICAL PROPERTIES Appearance white, viscous liquid Safety data N/A Melting point N/A Boiling point N/A Flash point N/A Ignition Temperature N/A Lower explosion limit N/A Upper Explosion limit N/A Water Solubility N/A
  • 5. Material Safety Data Sheet Version 1.1 Revision Date: 06/05/2014 Print Date: 08/06/2014 Density N/A 9. STABILITY AND REACITIVITY STORAGE STABILITY Store under recommended conditions. MATERIALS TO AVIOD Strong oxidizing agents, strong acids HAZARDOUS DECOMPOSITION PRODUCTS N/A CONDITIONS TO AVOID Light and exposure to moisture. Strong bases and Strong oxidizing agents. 10. TOXICOLOGICAL INFORMATION CARCINOGENICITY This product contains a component that has been reported to be carcinogenic based on its IARC, OHSA, ACGIH, NTP, or EPA classification. IARC: No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or confirmed human carcinogen by the IARC. OHSA: No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or confirmed human carcinogen by the OHSA. ACGIH: No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or confirmed human carcinogen by the ACGIH. EPA: No component of this product present at levels greater than or equal to 0.1% is identified as probable, possible or confirmed human carcinogen by the EPA. CHRONIC. Only select Regeristory or Toxic of Chemical Substances (RTECS) data as presented here. See actual entery RTECS for complete information. Product is harmful by ingestion. Repeated contact may cause allergic reactions in very susceptible persons. ACUTE TOXICITY 1,3-Butanediol : Oral LD50- mouse rat-698 mg/kg Symptoms: Sense organs and special senses (eye-lacrimation; muscle weakness; diarrhea) Dermal LD50- rabbit >20,000 mg/kg Glycerin: Oral LD50- mouse rat-698 mg/kg
  • 6. Material Safety Data Sheet Version 1.1 Revision Date: 06/05/2014 Print Date: 08/06/2014 Symptoms: Sense organs and special senses (eye-lacrimation; muscle weakness; diarrhea) Dermal LD50- rabbit >20,000 mg/kg ADDITIONAL INFORMATION Prolonged or repeated exposure may result in Nausea, Headache, or Vomiting Kidney- irregularities-based on Human evidence ROUTE OF EXPOSURE Skin Contact: May cause skin irritation. May produce an allergic reaction. Skin Absorption: May be harmful if absorbed through the skin Eye Contact: May Cause eye irritation and risk serious damage Inhalation: Materials may be irritating to mucous membranes and upper respiratory tract. Ingestion: May be harmful if swallowed. Ingestion may cause gastrointestinal irritation, nausea, vomiting and diarrhea. SIGNS AND SYMPTOMS OF EXPOSURE Symptoms have not be thoroughly investigated 11. ECOLOGICAL INFORMATION Elimination information (persistence and degradability) N/A Ecotoxicity effects N/A Further information on ecology N/A 12. DISPOSAL CONSIDERATIONS PRODUCT Observe all federal, state, and local environment regulations. Contact a licensed professional waste disposal service to remove this material . CONTAMINATED PACKAGING Observe all federal, state, and local environment regulations. 13. TRANSPROT INFORMATION DOT (US) Not dangerous goods
  • 7. Material Safety Data Sheet Version 1.1 Revision Date: 06/05/2014 Print Date: 08/06/2014 IMDG Not dangerous goods IATA Not dangerous goods 15. REGULATORY INFORMATION OSHA HAZARDS OSHA: Hazardous by definition of Hazard Communication Standard (29 SFR 1910.1200). EINECS: this product is on the European Inventory of Existing Commercial Chemical Substances SARA 302 COMPONENTS SARA 302: No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302 SARA 313 COMPONENTS SARA 313: This material does not contain any chemical components with known CAS numbers that exceed threshold (De Minimis) reporting levels establi shed be SARA Title III, Section 313 SARA 311/312 HAZARDS Acute health hazards, chronic health hazards , fire hazard MASSACHUSETTS RIGHT TO KNOW COMPONENTS CAS-No. Revision Date Glycerol 56-81-5 2007-03-01 PENNSYVANIA RIGHT TO KNOW COMPONENTS CAS-No. Revision Date L-α-PHOSPHATIDYLCHOLINE, hydrogenated 97281-48-6 1989-08-11 Glycerol 56-81-5 2007-03-01 Butane-1,3-diol 107-88-0 Water 7732-18-5 Resveratrol 501-36-0 NEW JERSEY RIGHT TO KNOW COMPONENTS CAS-No. Revision Date L-α-PHOSPHATIDYLCHOLINE, hydrogenated 97281-48-6 1989-08-11 Glycerol 56-81-5 2007-03-01 Butane-1,3-diol 107-88-0 Water 7732-18-5 Resveratrol 501-36-0
  • 8. Material Safety Data Sheet Version 1.1 Revision Date: 06/05/2014 Print Date: 08/06/2014 CALIFORNIA PROP. 65 COMPONENTS CAS-No. Revision Date L-α-PHOSPHATIDYLCHOLINE, hydrogenated 97281-48-6 1989-08-11 U.S Department of Homeland Security This product does not contain any DHS chemicals Canada This product has been classified in accordance with the hazard criteria of the Controlled Products Regulation (CPR) and the MSDS contains all the information required by the CPR. CAS# 7732185 is listed on Canada's DSL List TSCA CAS# 7732185 is listed on the TSCA Inventory 16. OTHER INFORMATION Copyright 2013 Encapsula NanoSciences LLC license granted to make unlimited paper copies for internal use only. The above information is believed to be correct but does not support to be all inclusive and shall be used only as a guide. The information in this document is based on the present state of our knowledge and is applicable to the product with regard to appropriate safety precautions. It does not represent any guarantee of the properties of the product. Encapsula NanoSciences LLC shall not be held liable for any damage resulting from handling or from contact with the above product.